Global Congenital Heart Disease Treatment Device Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Congenital Heart Disease Treatment Device Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 98

Published Date: 13 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Congenital heart disease (CHD) is a cardiovascular malformation caused by abnormal fetal heart and blood vessel development, and it is one of the most common congenital malformations.

According to our (Global Info Research) latest study, the global Congenital Heart Disease Treatment Device market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Congenital Heart Disease Treatment Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Congenital Heart Disease Treatment Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Congenital Heart Disease Treatment Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Congenital Heart Disease Treatment Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Congenital Heart Disease Treatment Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Congenital Heart Disease Treatment Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Congenital Heart Disease Treatment Device market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Medtronic plc, Beijing Balance Medical Technology, Med-Zenith and MicroPort, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Congenital Heart Disease Treatment Device market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Artificial Heart Valve
Bracket
Ventricular Assist Device (VAD)
Other

Market segment by Application
Adult
Children

Major players covered
Abbott
Medtronic plc
Beijing Balance Medical Technology
Med-Zenith
MicroPort
Weigao Holding Company Limited
CryoLife
Edwards LifeSciences

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Congenital Heart Disease Treatment Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Congenital Heart Disease Treatment Device, with price, sales, revenue and global market share of Congenital Heart Disease Treatment Device from 2018 to 2023.
Chapter 3, the Congenital Heart Disease Treatment Device competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Congenital Heart Disease Treatment Device breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Congenital Heart Disease Treatment Device market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Congenital Heart Disease Treatment Device.
Chapter 14 and 15, to describe Congenital Heart Disease Treatment Device sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Congenital Heart Disease Treatment Device
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Congenital Heart Disease Treatment Device Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Artificial Heart Valve
1.3.3 Bracket
1.3.4 Ventricular Assist Device (VAD)
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Congenital Heart Disease Treatment Device Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adult
1.4.3 Children
1.5 Global Congenital Heart Disease Treatment Device Market Size & Forecast
1.5.1 Global Congenital Heart Disease Treatment Device Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Congenital Heart Disease Treatment Device Sales Quantity (2018-2029)
1.5.3 Global Congenital Heart Disease Treatment Device Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Congenital Heart Disease Treatment Device Product and Services
2.1.4 Abbott Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Recent Developments/Updates
2.2 Medtronic plc
2.2.1 Medtronic plc Details
2.2.2 Medtronic plc Major Business
2.2.3 Medtronic plc Congenital Heart Disease Treatment Device Product and Services
2.2.4 Medtronic plc Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Medtronic plc Recent Developments/Updates
2.3 Beijing Balance Medical Technology
2.3.1 Beijing Balance Medical Technology Details
2.3.2 Beijing Balance Medical Technology Major Business
2.3.3 Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Product and Services
2.3.4 Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Beijing Balance Medical Technology Recent Developments/Updates
2.4 Med-Zenith
2.4.1 Med-Zenith Details
2.4.2 Med-Zenith Major Business
2.4.3 Med-Zenith Congenital Heart Disease Treatment Device Product and Services
2.4.4 Med-Zenith Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Med-Zenith Recent Developments/Updates
2.5 MicroPort
2.5.1 MicroPort Details
2.5.2 MicroPort Major Business
2.5.3 MicroPort Congenital Heart Disease Treatment Device Product and Services
2.5.4 MicroPort Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MicroPort Recent Developments/Updates
2.6 Weigao Holding Company Limited
2.6.1 Weigao Holding Company Limited Details
2.6.2 Weigao Holding Company Limited Major Business
2.6.3 Weigao Holding Company Limited Congenital Heart Disease Treatment Device Product and Services
2.6.4 Weigao Holding Company Limited Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Weigao Holding Company Limited Recent Developments/Updates
2.7 CryoLife
2.7.1 CryoLife Details
2.7.2 CryoLife Major Business
2.7.3 CryoLife Congenital Heart Disease Treatment Device Product and Services
2.7.4 CryoLife Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CryoLife Recent Developments/Updates
2.8 Edwards LifeSciences
2.8.1 Edwards LifeSciences Details
2.8.2 Edwards LifeSciences Major Business
2.8.3 Edwards LifeSciences Congenital Heart Disease Treatment Device Product and Services
2.8.4 Edwards LifeSciences Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Edwards LifeSciences Recent Developments/Updates

3 Competitive Environment: Congenital Heart Disease Treatment Device by Manufacturer
3.1 Global Congenital Heart Disease Treatment Device Sales Quantity by Manufacturer (2018-2023)
3.2 Global Congenital Heart Disease Treatment Device Revenue by Manufacturer (2018-2023)
3.3 Global Congenital Heart Disease Treatment Device Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Congenital Heart Disease Treatment Device by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Congenital Heart Disease Treatment Device Manufacturer Market Share in 2022
3.4.2 Top 6 Congenital Heart Disease Treatment Device Manufacturer Market Share in 2022
3.5 Congenital Heart Disease Treatment Device Market: Overall Company Footprint Analysis
3.5.1 Congenital Heart Disease Treatment Device Market: Region Footprint
3.5.2 Congenital Heart Disease Treatment Device Market: Company Product Type Footprint
3.5.3 Congenital Heart Disease Treatment Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Congenital Heart Disease Treatment Device Market Size by Region
4.1.1 Global Congenital Heart Disease Treatment Device Sales Quantity by Region (2018-2029)
4.1.2 Global Congenital Heart Disease Treatment Device Consumption Value by Region (2018-2029)
4.1.3 Global Congenital Heart Disease Treatment Device Average Price by Region (2018-2029)
4.2 North America Congenital Heart Disease Treatment Device Consumption Value (2018-2029)
4.3 Europe Congenital Heart Disease Treatment Device Consumption Value (2018-2029)
4.4 Asia-Pacific Congenital Heart Disease Treatment Device Consumption Value (2018-2029)
4.5 South America Congenital Heart Disease Treatment Device Consumption Value (2018-2029)
4.6 Middle East and Africa Congenital Heart Disease Treatment Device Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2029)
5.2 Global Congenital Heart Disease Treatment Device Consumption Value by Type (2018-2029)
5.3 Global Congenital Heart Disease Treatment Device Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2029)
6.2 Global Congenital Heart Disease Treatment Device Consumption Value by Application (2018-2029)
6.3 Global Congenital Heart Disease Treatment Device Average Price by Application (2018-2029)

7 North America
7.1 North America Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2029)
7.2 North America Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2029)
7.3 North America Congenital Heart Disease Treatment Device Market Size by Country
7.3.1 North America Congenital Heart Disease Treatment Device Sales Quantity by Country (2018-2029)
7.3.2 North America Congenital Heart Disease Treatment Device Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2029)
8.2 Europe Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2029)
8.3 Europe Congenital Heart Disease Treatment Device Market Size by Country
8.3.1 Europe Congenital Heart Disease Treatment Device Sales Quantity by Country (2018-2029)
8.3.2 Europe Congenital Heart Disease Treatment Device Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Congenital Heart Disease Treatment Device Market Size by Region
9.3.1 Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Congenital Heart Disease Treatment Device Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2029)
10.2 South America Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2029)
10.3 South America Congenital Heart Disease Treatment Device Market Size by Country
10.3.1 South America Congenital Heart Disease Treatment Device Sales Quantity by Country (2018-2029)
10.3.2 South America Congenital Heart Disease Treatment Device Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Congenital Heart Disease Treatment Device Market Size by Country
11.3.1 Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Congenital Heart Disease Treatment Device Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Congenital Heart Disease Treatment Device Market Drivers
12.2 Congenital Heart Disease Treatment Device Market Restraints
12.3 Congenital Heart Disease Treatment Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Congenital Heart Disease Treatment Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Congenital Heart Disease Treatment Device
13.3 Congenital Heart Disease Treatment Device Production Process
13.4 Congenital Heart Disease Treatment Device Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Congenital Heart Disease Treatment Device Typical Distributors
14.3 Congenital Heart Disease Treatment Device Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Congenital Heart Disease Treatment Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Congenital Heart Disease Treatment Device Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Congenital Heart Disease Treatment Device Product and Services
Table 6. Abbott Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Abbott Recent Developments/Updates
Table 8. Medtronic plc Basic Information, Manufacturing Base and Competitors
Table 9. Medtronic plc Major Business
Table 10. Medtronic plc Congenital Heart Disease Treatment Device Product and Services
Table 11. Medtronic plc Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Medtronic plc Recent Developments/Updates
Table 13. Beijing Balance Medical Technology Basic Information, Manufacturing Base and Competitors
Table 14. Beijing Balance Medical Technology Major Business
Table 15. Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Product and Services
Table 16. Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Beijing Balance Medical Technology Recent Developments/Updates
Table 18. Med-Zenith Basic Information, Manufacturing Base and Competitors
Table 19. Med-Zenith Major Business
Table 20. Med-Zenith Congenital Heart Disease Treatment Device Product and Services
Table 21. Med-Zenith Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Med-Zenith Recent Developments/Updates
Table 23. MicroPort Basic Information, Manufacturing Base and Competitors
Table 24. MicroPort Major Business
Table 25. MicroPort Congenital Heart Disease Treatment Device Product and Services
Table 26. MicroPort Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. MicroPort Recent Developments/Updates
Table 28. Weigao Holding Company Limited Basic Information, Manufacturing Base and Competitors
Table 29. Weigao Holding Company Limited Major Business
Table 30. Weigao Holding Company Limited Congenital Heart Disease Treatment Device Product and Services
Table 31. Weigao Holding Company Limited Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Weigao Holding Company Limited Recent Developments/Updates
Table 33. CryoLife Basic Information, Manufacturing Base and Competitors
Table 34. CryoLife Major Business
Table 35. CryoLife Congenital Heart Disease Treatment Device Product and Services
Table 36. CryoLife Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. CryoLife Recent Developments/Updates
Table 38. Edwards LifeSciences Basic Information, Manufacturing Base and Competitors
Table 39. Edwards LifeSciences Major Business
Table 40. Edwards LifeSciences Congenital Heart Disease Treatment Device Product and Services
Table 41. Edwards LifeSciences Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Edwards LifeSciences Recent Developments/Updates
Table 43. Global Congenital Heart Disease Treatment Device Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global Congenital Heart Disease Treatment Device Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Congenital Heart Disease Treatment Device Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 46. Market Position of Manufacturers in Congenital Heart Disease Treatment Device, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Congenital Heart Disease Treatment Device Production Site of Key Manufacturer
Table 48. Congenital Heart Disease Treatment Device Market: Company Product Type Footprint
Table 49. Congenital Heart Disease Treatment Device Market: Company Product Application Footprint
Table 50. Congenital Heart Disease Treatment Device New Market Entrants and Barriers to Market Entry
Table 51. Congenital Heart Disease Treatment Device Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Congenital Heart Disease Treatment Device Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global Congenital Heart Disease Treatment Device Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global Congenital Heart Disease Treatment Device Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Congenital Heart Disease Treatment Device Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Congenital Heart Disease Treatment Device Average Price by Region (2018-2023) & (US$/Unit)
Table 57. Global Congenital Heart Disease Treatment Device Average Price by Region (2024-2029) & (US$/Unit)
Table 58. Global Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global Congenital Heart Disease Treatment Device Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global Congenital Heart Disease Treatment Device Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Congenital Heart Disease Treatment Device Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Congenital Heart Disease Treatment Device Average Price by Type (2018-2023) & (US$/Unit)
Table 63. Global Congenital Heart Disease Treatment Device Average Price by Type (2024-2029) & (US$/Unit)
Table 64. Global Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global Congenital Heart Disease Treatment Device Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global Congenital Heart Disease Treatment Device Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Congenital Heart Disease Treatment Device Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Congenital Heart Disease Treatment Device Average Price by Application (2018-2023) & (US$/Unit)
Table 69. Global Congenital Heart Disease Treatment Device Average Price by Application (2024-2029) & (US$/Unit)
Table 70. North America Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America Congenital Heart Disease Treatment Device Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America Congenital Heart Disease Treatment Device Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America Congenital Heart Disease Treatment Device Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America Congenital Heart Disease Treatment Device Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America Congenital Heart Disease Treatment Device Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Congenital Heart Disease Treatment Device Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe Congenital Heart Disease Treatment Device Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe Congenital Heart Disease Treatment Device Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe Congenital Heart Disease Treatment Device Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe Congenital Heart Disease Treatment Device Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe Congenital Heart Disease Treatment Device Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Congenital Heart Disease Treatment Device Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific Congenital Heart Disease Treatment Device Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Congenital Heart Disease Treatment Device Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America Congenital Heart Disease Treatment Device Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America Congenital Heart Disease Treatment Device Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America Congenital Heart Disease Treatment Device Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America Congenital Heart Disease Treatment Device Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America Congenital Heart Disease Treatment Device Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Congenital Heart Disease Treatment Device Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa Congenital Heart Disease Treatment Device Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Congenital Heart Disease Treatment Device Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Congenital Heart Disease Treatment Device Raw Material
Table 111. Key Manufacturers of Congenital Heart Disease Treatment Device Raw Materials
Table 112. Congenital Heart Disease Treatment Device Typical Distributors
Table 113. Congenital Heart Disease Treatment Device Typical Customers
List of Figures
Figure 1. Congenital Heart Disease Treatment Device Picture
Figure 2. Global Congenital Heart Disease Treatment Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Congenital Heart Disease Treatment Device Consumption Value Market Share by Type in 2022
Figure 4. Artificial Heart Valve Examples
Figure 5. Bracket Examples
Figure 6. Ventricular Assist Device (VAD) Examples
Figure 7. Other Examples
Figure 8. Global Congenital Heart Disease Treatment Device Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Congenital Heart Disease Treatment Device Consumption Value Market Share by Application in 2022
Figure 10. Adult Examples
Figure 11. Children Examples
Figure 12. Global Congenital Heart Disease Treatment Device Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Congenital Heart Disease Treatment Device Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Congenital Heart Disease Treatment Device Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Congenital Heart Disease Treatment Device Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Congenital Heart Disease Treatment Device Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Congenital Heart Disease Treatment Device Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Congenital Heart Disease Treatment Device by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Congenital Heart Disease Treatment Device Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Congenital Heart Disease Treatment Device Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Congenital Heart Disease Treatment Device Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Congenital Heart Disease Treatment Device Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Congenital Heart Disease Treatment Device Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Congenital Heart Disease Treatment Device Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Congenital Heart Disease Treatment Device Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Congenital Heart Disease Treatment Device Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Congenital Heart Disease Treatment Device Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Congenital Heart Disease Treatment Device Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Congenital Heart Disease Treatment Device Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Congenital Heart Disease Treatment Device Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Congenital Heart Disease Treatment Device Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Congenital Heart Disease Treatment Device Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Congenital Heart Disease Treatment Device Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Congenital Heart Disease Treatment Device Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Congenital Heart Disease Treatment Device Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Congenital Heart Disease Treatment Device Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Congenital Heart Disease Treatment Device Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Congenital Heart Disease Treatment Device Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Congenital Heart Disease Treatment Device Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Congenital Heart Disease Treatment Device Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Congenital Heart Disease Treatment Device Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Congenital Heart Disease Treatment Device Consumption Value Market Share by Region (2018-2029)
Figure 54. China Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Congenital Heart Disease Treatment Device Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Congenital Heart Disease Treatment Device Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Congenital Heart Disease Treatment Device Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Congenital Heart Disease Treatment Device Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Congenital Heart Disease Treatment Device Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Congenital Heart Disease Treatment Device Market Drivers
Figure 75. Congenital Heart Disease Treatment Device Market Restraints
Figure 76. Congenital Heart Disease Treatment Device Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Congenital Heart Disease Treatment Device in 2022
Figure 79. Manufacturing Process Analysis of Congenital Heart Disease Treatment Device
Figure 80. Congenital Heart Disease Treatment Device Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Abbott
Medtronic plc
Beijing Balance Medical Technology
Med-Zenith
MicroPort
Weigao Holding Company Limited
CryoLife
Edwards LifeSciences
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Congenital Heart Disease Treatment Device Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Congenital Heart Disease Treatment Device Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 98

Published Date: 13 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Congenital heart disease (CHD) is a cardiovascular malformation caused by abnormal fetal heart and blood vessel development, and it is one of the most common congenital malformations.

According to our (Global Info Research) latest study, the global Congenital Heart Disease Treatment Device market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Congenital Heart Disease Treatment Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Congenital Heart Disease Treatment Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Congenital Heart Disease Treatment Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Congenital Heart Disease Treatment Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Congenital Heart Disease Treatment Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Congenital Heart Disease Treatment Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Congenital Heart Disease Treatment Device market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Medtronic plc, Beijing Balance Medical Technology, Med-Zenith and MicroPort, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Congenital Heart Disease Treatment Device market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Artificial Heart Valve
Bracket
Ventricular Assist Device (VAD)
Other

Market segment by Application
Adult
Children

Major players covered
Abbott
Medtronic plc
Beijing Balance Medical Technology
Med-Zenith
MicroPort
Weigao Holding Company Limited
CryoLife
Edwards LifeSciences

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Congenital Heart Disease Treatment Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Congenital Heart Disease Treatment Device, with price, sales, revenue and global market share of Congenital Heart Disease Treatment Device from 2018 to 2023.
Chapter 3, the Congenital Heart Disease Treatment Device competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Congenital Heart Disease Treatment Device breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Congenital Heart Disease Treatment Device market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Congenital Heart Disease Treatment Device.
Chapter 14 and 15, to describe Congenital Heart Disease Treatment Device sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Congenital Heart Disease Treatment Device
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Congenital Heart Disease Treatment Device Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Artificial Heart Valve
1.3.3 Bracket
1.3.4 Ventricular Assist Device (VAD)
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Congenital Heart Disease Treatment Device Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adult
1.4.3 Children
1.5 Global Congenital Heart Disease Treatment Device Market Size & Forecast
1.5.1 Global Congenital Heart Disease Treatment Device Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Congenital Heart Disease Treatment Device Sales Quantity (2018-2029)
1.5.3 Global Congenital Heart Disease Treatment Device Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Congenital Heart Disease Treatment Device Product and Services
2.1.4 Abbott Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Recent Developments/Updates
2.2 Medtronic plc
2.2.1 Medtronic plc Details
2.2.2 Medtronic plc Major Business
2.2.3 Medtronic plc Congenital Heart Disease Treatment Device Product and Services
2.2.4 Medtronic plc Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Medtronic plc Recent Developments/Updates
2.3 Beijing Balance Medical Technology
2.3.1 Beijing Balance Medical Technology Details
2.3.2 Beijing Balance Medical Technology Major Business
2.3.3 Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Product and Services
2.3.4 Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Beijing Balance Medical Technology Recent Developments/Updates
2.4 Med-Zenith
2.4.1 Med-Zenith Details
2.4.2 Med-Zenith Major Business
2.4.3 Med-Zenith Congenital Heart Disease Treatment Device Product and Services
2.4.4 Med-Zenith Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Med-Zenith Recent Developments/Updates
2.5 MicroPort
2.5.1 MicroPort Details
2.5.2 MicroPort Major Business
2.5.3 MicroPort Congenital Heart Disease Treatment Device Product and Services
2.5.4 MicroPort Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MicroPort Recent Developments/Updates
2.6 Weigao Holding Company Limited
2.6.1 Weigao Holding Company Limited Details
2.6.2 Weigao Holding Company Limited Major Business
2.6.3 Weigao Holding Company Limited Congenital Heart Disease Treatment Device Product and Services
2.6.4 Weigao Holding Company Limited Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Weigao Holding Company Limited Recent Developments/Updates
2.7 CryoLife
2.7.1 CryoLife Details
2.7.2 CryoLife Major Business
2.7.3 CryoLife Congenital Heart Disease Treatment Device Product and Services
2.7.4 CryoLife Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CryoLife Recent Developments/Updates
2.8 Edwards LifeSciences
2.8.1 Edwards LifeSciences Details
2.8.2 Edwards LifeSciences Major Business
2.8.3 Edwards LifeSciences Congenital Heart Disease Treatment Device Product and Services
2.8.4 Edwards LifeSciences Congenital Heart Disease Treatment Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Edwards LifeSciences Recent Developments/Updates

3 Competitive Environment: Congenital Heart Disease Treatment Device by Manufacturer
3.1 Global Congenital Heart Disease Treatment Device Sales Quantity by Manufacturer (2018-2023)
3.2 Global Congenital Heart Disease Treatment Device Revenue by Manufacturer (2018-2023)
3.3 Global Congenital Heart Disease Treatment Device Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Congenital Heart Disease Treatment Device by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Congenital Heart Disease Treatment Device Manufacturer Market Share in 2022
3.4.2 Top 6 Congenital Heart Disease Treatment Device Manufacturer Market Share in 2022
3.5 Congenital Heart Disease Treatment Device Market: Overall Company Footprint Analysis
3.5.1 Congenital Heart Disease Treatment Device Market: Region Footprint
3.5.2 Congenital Heart Disease Treatment Device Market: Company Product Type Footprint
3.5.3 Congenital Heart Disease Treatment Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Congenital Heart Disease Treatment Device Market Size by Region
4.1.1 Global Congenital Heart Disease Treatment Device Sales Quantity by Region (2018-2029)
4.1.2 Global Congenital Heart Disease Treatment Device Consumption Value by Region (2018-2029)
4.1.3 Global Congenital Heart Disease Treatment Device Average Price by Region (2018-2029)
4.2 North America Congenital Heart Disease Treatment Device Consumption Value (2018-2029)
4.3 Europe Congenital Heart Disease Treatment Device Consumption Value (2018-2029)
4.4 Asia-Pacific Congenital Heart Disease Treatment Device Consumption Value (2018-2029)
4.5 South America Congenital Heart Disease Treatment Device Consumption Value (2018-2029)
4.6 Middle East and Africa Congenital Heart Disease Treatment Device Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2029)
5.2 Global Congenital Heart Disease Treatment Device Consumption Value by Type (2018-2029)
5.3 Global Congenital Heart Disease Treatment Device Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2029)
6.2 Global Congenital Heart Disease Treatment Device Consumption Value by Application (2018-2029)
6.3 Global Congenital Heart Disease Treatment Device Average Price by Application (2018-2029)

7 North America
7.1 North America Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2029)
7.2 North America Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2029)
7.3 North America Congenital Heart Disease Treatment Device Market Size by Country
7.3.1 North America Congenital Heart Disease Treatment Device Sales Quantity by Country (2018-2029)
7.3.2 North America Congenital Heart Disease Treatment Device Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2029)
8.2 Europe Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2029)
8.3 Europe Congenital Heart Disease Treatment Device Market Size by Country
8.3.1 Europe Congenital Heart Disease Treatment Device Sales Quantity by Country (2018-2029)
8.3.2 Europe Congenital Heart Disease Treatment Device Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Congenital Heart Disease Treatment Device Market Size by Region
9.3.1 Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Congenital Heart Disease Treatment Device Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2029)
10.2 South America Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2029)
10.3 South America Congenital Heart Disease Treatment Device Market Size by Country
10.3.1 South America Congenital Heart Disease Treatment Device Sales Quantity by Country (2018-2029)
10.3.2 South America Congenital Heart Disease Treatment Device Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Congenital Heart Disease Treatment Device Market Size by Country
11.3.1 Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Congenital Heart Disease Treatment Device Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Congenital Heart Disease Treatment Device Market Drivers
12.2 Congenital Heart Disease Treatment Device Market Restraints
12.3 Congenital Heart Disease Treatment Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Congenital Heart Disease Treatment Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Congenital Heart Disease Treatment Device
13.3 Congenital Heart Disease Treatment Device Production Process
13.4 Congenital Heart Disease Treatment Device Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Congenital Heart Disease Treatment Device Typical Distributors
14.3 Congenital Heart Disease Treatment Device Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Congenital Heart Disease Treatment Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Congenital Heart Disease Treatment Device Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Congenital Heart Disease Treatment Device Product and Services
Table 6. Abbott Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Abbott Recent Developments/Updates
Table 8. Medtronic plc Basic Information, Manufacturing Base and Competitors
Table 9. Medtronic plc Major Business
Table 10. Medtronic plc Congenital Heart Disease Treatment Device Product and Services
Table 11. Medtronic plc Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Medtronic plc Recent Developments/Updates
Table 13. Beijing Balance Medical Technology Basic Information, Manufacturing Base and Competitors
Table 14. Beijing Balance Medical Technology Major Business
Table 15. Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Product and Services
Table 16. Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Beijing Balance Medical Technology Recent Developments/Updates
Table 18. Med-Zenith Basic Information, Manufacturing Base and Competitors
Table 19. Med-Zenith Major Business
Table 20. Med-Zenith Congenital Heart Disease Treatment Device Product and Services
Table 21. Med-Zenith Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Med-Zenith Recent Developments/Updates
Table 23. MicroPort Basic Information, Manufacturing Base and Competitors
Table 24. MicroPort Major Business
Table 25. MicroPort Congenital Heart Disease Treatment Device Product and Services
Table 26. MicroPort Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. MicroPort Recent Developments/Updates
Table 28. Weigao Holding Company Limited Basic Information, Manufacturing Base and Competitors
Table 29. Weigao Holding Company Limited Major Business
Table 30. Weigao Holding Company Limited Congenital Heart Disease Treatment Device Product and Services
Table 31. Weigao Holding Company Limited Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Weigao Holding Company Limited Recent Developments/Updates
Table 33. CryoLife Basic Information, Manufacturing Base and Competitors
Table 34. CryoLife Major Business
Table 35. CryoLife Congenital Heart Disease Treatment Device Product and Services
Table 36. CryoLife Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. CryoLife Recent Developments/Updates
Table 38. Edwards LifeSciences Basic Information, Manufacturing Base and Competitors
Table 39. Edwards LifeSciences Major Business
Table 40. Edwards LifeSciences Congenital Heart Disease Treatment Device Product and Services
Table 41. Edwards LifeSciences Congenital Heart Disease Treatment Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Edwards LifeSciences Recent Developments/Updates
Table 43. Global Congenital Heart Disease Treatment Device Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global Congenital Heart Disease Treatment Device Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Congenital Heart Disease Treatment Device Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 46. Market Position of Manufacturers in Congenital Heart Disease Treatment Device, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Congenital Heart Disease Treatment Device Production Site of Key Manufacturer
Table 48. Congenital Heart Disease Treatment Device Market: Company Product Type Footprint
Table 49. Congenital Heart Disease Treatment Device Market: Company Product Application Footprint
Table 50. Congenital Heart Disease Treatment Device New Market Entrants and Barriers to Market Entry
Table 51. Congenital Heart Disease Treatment Device Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Congenital Heart Disease Treatment Device Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global Congenital Heart Disease Treatment Device Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global Congenital Heart Disease Treatment Device Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Congenital Heart Disease Treatment Device Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Congenital Heart Disease Treatment Device Average Price by Region (2018-2023) & (US$/Unit)
Table 57. Global Congenital Heart Disease Treatment Device Average Price by Region (2024-2029) & (US$/Unit)
Table 58. Global Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global Congenital Heart Disease Treatment Device Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global Congenital Heart Disease Treatment Device Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Congenital Heart Disease Treatment Device Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Congenital Heart Disease Treatment Device Average Price by Type (2018-2023) & (US$/Unit)
Table 63. Global Congenital Heart Disease Treatment Device Average Price by Type (2024-2029) & (US$/Unit)
Table 64. Global Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global Congenital Heart Disease Treatment Device Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global Congenital Heart Disease Treatment Device Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Congenital Heart Disease Treatment Device Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Congenital Heart Disease Treatment Device Average Price by Application (2018-2023) & (US$/Unit)
Table 69. Global Congenital Heart Disease Treatment Device Average Price by Application (2024-2029) & (US$/Unit)
Table 70. North America Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America Congenital Heart Disease Treatment Device Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America Congenital Heart Disease Treatment Device Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America Congenital Heart Disease Treatment Device Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America Congenital Heart Disease Treatment Device Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America Congenital Heart Disease Treatment Device Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Congenital Heart Disease Treatment Device Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe Congenital Heart Disease Treatment Device Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe Congenital Heart Disease Treatment Device Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe Congenital Heart Disease Treatment Device Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe Congenital Heart Disease Treatment Device Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe Congenital Heart Disease Treatment Device Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Congenital Heart Disease Treatment Device Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific Congenital Heart Disease Treatment Device Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Congenital Heart Disease Treatment Device Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America Congenital Heart Disease Treatment Device Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America Congenital Heart Disease Treatment Device Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America Congenital Heart Disease Treatment Device Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America Congenital Heart Disease Treatment Device Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America Congenital Heart Disease Treatment Device Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Congenital Heart Disease Treatment Device Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa Congenital Heart Disease Treatment Device Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Congenital Heart Disease Treatment Device Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Congenital Heart Disease Treatment Device Raw Material
Table 111. Key Manufacturers of Congenital Heart Disease Treatment Device Raw Materials
Table 112. Congenital Heart Disease Treatment Device Typical Distributors
Table 113. Congenital Heart Disease Treatment Device Typical Customers
List of Figures
Figure 1. Congenital Heart Disease Treatment Device Picture
Figure 2. Global Congenital Heart Disease Treatment Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Congenital Heart Disease Treatment Device Consumption Value Market Share by Type in 2022
Figure 4. Artificial Heart Valve Examples
Figure 5. Bracket Examples
Figure 6. Ventricular Assist Device (VAD) Examples
Figure 7. Other Examples
Figure 8. Global Congenital Heart Disease Treatment Device Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Congenital Heart Disease Treatment Device Consumption Value Market Share by Application in 2022
Figure 10. Adult Examples
Figure 11. Children Examples
Figure 12. Global Congenital Heart Disease Treatment Device Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Congenital Heart Disease Treatment Device Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Congenital Heart Disease Treatment Device Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Congenital Heart Disease Treatment Device Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Congenital Heart Disease Treatment Device Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Congenital Heart Disease Treatment Device Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Congenital Heart Disease Treatment Device by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Congenital Heart Disease Treatment Device Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Congenital Heart Disease Treatment Device Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Congenital Heart Disease Treatment Device Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Congenital Heart Disease Treatment Device Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Congenital Heart Disease Treatment Device Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Congenital Heart Disease Treatment Device Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Congenital Heart Disease Treatment Device Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Congenital Heart Disease Treatment Device Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Congenital Heart Disease Treatment Device Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Congenital Heart Disease Treatment Device Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Congenital Heart Disease Treatment Device Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Congenital Heart Disease Treatment Device Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Congenital Heart Disease Treatment Device Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Congenital Heart Disease Treatment Device Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Congenital Heart Disease Treatment Device Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Congenital Heart Disease Treatment Device Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Congenital Heart Disease Treatment Device Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Congenital Heart Disease Treatment Device Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Congenital Heart Disease Treatment Device Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Congenital Heart Disease Treatment Device Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Congenital Heart Disease Treatment Device Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Congenital Heart Disease Treatment Device Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Congenital Heart Disease Treatment Device Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Congenital Heart Disease Treatment Device Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Congenital Heart Disease Treatment Device Consumption Value Market Share by Region (2018-2029)
Figure 54. China Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Congenital Heart Disease Treatment Device Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Congenital Heart Disease Treatment Device Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Congenital Heart Disease Treatment Device Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Congenital Heart Disease Treatment Device Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Congenital Heart Disease Treatment Device Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Congenital Heart Disease Treatment Device Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Congenital Heart Disease Treatment Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Congenital Heart Disease Treatment Device Market Drivers
Figure 75. Congenital Heart Disease Treatment Device Market Restraints
Figure 76. Congenital Heart Disease Treatment Device Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Congenital Heart Disease Treatment Device in 2022
Figure 79. Manufacturing Process Analysis of Congenital Heart Disease Treatment Device
Figure 80. Congenital Heart Disease Treatment Device Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Abbott
Medtronic plc
Beijing Balance Medical Technology
Med-Zenith
MicroPort
Weigao Holding Company Limited
CryoLife
Edwards LifeSciences
jiaGou

Add To Cart

gouMai

Buy Now